name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 12.9 g in 100 g TOPICAL STICK [Dove Powder Finish Dry Serum Antiperspirant]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 100 mg in 1 g TOPICAL STICK [Mens Speed Stick Stainguard Clean - antiperspirant/deodorant]


name: AMINO ACIDS, HAIR KERATIN 100 mg in 1 g TOPICAL GEL [keroxx]


name: syringe with needle,insulin,0.3 mL 30 gauge X 15/64" MISCELL SYRINGE, EMPTY DISPOSABLE


name: Niacinamide 0.07 g in 3.5 mL / Adenosine 0.001 g in 3.5 mL TOPICAL SOLUTION [reFACE TOX AMPULE]


name: Niacinamide 0.56 g in 28 g TOPICAL PATCH [Skin Project Ya Cooling Celluven Mask]


name: Formula, Infant Oral Powder for Suspension [Gentle Infant Formula]


name: Formula, Infant Oral Powder for Suspension [Gerber Natura Toddler]


name: Formula, Infant Oral Powder for Suspension [Gerber Natura Infant Formula]


name: Medical Food Oral Suspension [CeraLyte 70]


name: OCTINOXATE 2.1 mg in 30 mL / OCTISALATE 0.9 mg in 30 mL / TITANIUM DIOXIDE 2.51454 mg in 30 mL TOPICAL CREAM [CLE CCC Golden Medium Deep]


name: Ascorbic Acid/Biotin/Calcium/Copper/Cyanocobalamin/Folic Acid/Iodine/Iron/Magnesium/Niacin/Pantothenic Acid/Pyridoxine/Riboflavin/Thiamine/Vitamin A/Vitamin D/Vitamin E/Zinc;Docosahexaenoic Acid 60 MG-300 MCG-300 MG-2 MG-8 MCG-975 MCG-150 MCG-28 MG-50 MG-20 MG-10 MG-2.5 MG-2 MG-1.7 MG-4000 IU-400 IU-30 IU-15 MG; 200 MG Oral Kit


name: Ascorbic Acid/Biotin/Calcium/Copper/Cyanocobalamin/Folic Acid/Iodine/Iron/Magnesium/Niacin/Pantothenic Acid/Pyridoxine/Riboflavin/Thiamine/Vitamin A/Vitamin D/Vitamin E/Zinc;Docosahexaenoic Acid 60 MG-300 MCG-300 MG-2 MG-8 MCG-975 MCG-150 MCG-28 MG-50 MG-20 MG-10 MG-2.5 MG-2 MG-1.7 MG-4000 IU-400 IU-30 IU-15 MG; 200 MG Oral Kit [Women's Prenatal+DHA]


name: Silicone Topical application Sheet [Siltrex]


name: triethanolamine salicylate MISCELL LIQUID (GRAM)


name: Gel, Multi Ingredient Topical application Gel/Jelly [PCCA W06]


name: Capsaicin;Diclofenac Sodium 0.025%; 1.5% Multiple Routes Kit [CapsFenac Pak]


name: ZINC OXIDE 11 g in 100 g TOPICAL STICK [ALL WEATHER SPF 15 LIP BALM]


name: BANDAGE,HIGH COMPRESSION 4IN X 3.8YD MOLNLYCKE


name: DRESSING,AQUACEL AG ADVANTAGE 6IN X 6IN C#422298


name: DRESSING,BORDER 6IN X 6IN RELIAMED #ZGB66


name: DRESSING,COLLAGEN EXTRACELLULAR MATRIX 2IN X 2IN #529311


name: DRESSING,COLLAGEN EXTRACELLULAR MATRIX 2IN X 2IN #529312


name: DRESSING,COLLAGEN EXTRACELLULAR MATRIX 4IN X 5IN #529313


name: DRESSING,COLLAGEN EXTRACELLULAR MATRIX 4IN X 5IN #529314


name: EXTERNAL CONTINENCE DEVICE BIODERM #210268


name: SET,INFUSION AUTOSOFT XC TANDEM #1001681


name: SET,INFUSION AUTOSOFT XC TANDEM #1001728


name: SKIN PROTECTANT,CAVILON ADVANCED 3M#5050


name: VAD DRIVELINE MAINTENANCE KIT CENTURION #DM940


name: mometasone / orbifloxacin / posaconazole


name: Ethylhexyl triazone 50 mg in 1 mL / Diethylamino hydroxybenzoyl hexyl benzoate 30 mg in 1 mL / BEMOTRIZINOL 30 mg in 1 mL / DROMETRIZOLE TRISILOXANE 10 mg in 1 mL / TITANIUM DIOXIDE 25 mg in 1 mL TOPICAL GEL [Kiehls Ultra Light Daily UV Defense Aqua Gel SPF 50 Anti-Pollution]


name: Neutrogena Sensitive Skin SPF50 Face Lotion


name: AVOBENZONE 2 g in 100 mL / ENSULIZOLE 1.5 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 1.3 g in 100 mL TOPICAL LOTION [Simple Light Moisturizer SPF 15]


name: ILEX PARAGUARIENSIS LEAF 3.0 g in 150 mL TOPICAL CREAM [LEBODY FIT BODY MASSAGER PLUS]


name: OCTINOXATE 3.25 g in 50 mL / TITANIUM DIOXIDE 1.765 g in 50 mL TOPICAL LOTION [BOTANIC TWENTY DAILY SUNBLOCK SPF50]


name: GLUCOCARD Shine Connex Blood Glucose Monitoring System


name: GLUCOCARD Shine Express Blood Glucose Monitoring System


name: AVOBENZONE 0.03 g in 1 mL / OCTISALATE 0.045 g in 1 mL / OCTOCRYLENE 0.027 g in 1 mL TOPICAL CREAM [RESILIENCE MULTI-EFFECT TRI-PEPTIDE FACE AND NECK CREME BROAD SPECTRUM SPF 15 dry skin]


name: ADENOSINE 0.04 g in 150 mL / NIACINAMIDE 2 g in 150 mL TOPICAL GEL [BOTANIC TWENTY HYPERCARE ESSENCE]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 12.9 g in 100 g TOPICAL STICK [Dove Jasmine Finish Dry Serum Antiperspirant]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 12.9 g in 100 g TOPICAL STICK [Dove Rose Finish Dry Serum Antiperspirant]


name: protectives combination no.6 TOPICAL GEL (GRAM)


name: hypochlorous acid/sodium chloride/sodium phosphate TOPICAL SPRAY, NON-AEROSOL (ML)


name: HOMOSALATE 80 mg in 1 mL / OCTINOXATE 70 mg in 1 mL / PADIMATE O 42 mg in 1 mL / OXYBENZONE 30 mg in 1 mL TOPICAL LOTION [Aruba Aloe Very Water Resistant Sunscreen - For Faces SPF 30]


name: OCTINOXATE 63.1 mg in 1 g / TITANIUM DIOXIDE 31.6 mg in 1 g TOPICAL CREAM [Avon True Color Flawless Cream to Powder Foundation]


name: OXYBENZONE 20 mg in 1 mL / OCTINOXATE 70 mg in 1 mL TOPICAL LOTION [Aruba Aloe Very Water Resistant Sunscreen SPF 8]


name: OXYBENZONE 45 mg in 1 mL / OCTINOXATE 75 mg in 1 mL TOPICAL LOTION [Aruba Aloe Very Water Resistant Sunscreen SPF 15]


name: OCTINOXATE 75 mg in 1 mL / OXYBENZONE 45 mg in 1 mL TOPICAL CREAM [ARUBA ALOE ISLAND REMEDY DAILY ULTRA ALOE]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 15 g in 100 g TOPICAL STICK [Old Spice Volcano with Charcoal]


name: Univ of Vermont Medical Center Amenity KIT


name: ZINC OXIDE 63 mg in 1 mL / TITANIUM DIOXIDE 23.6 mg in 1 mL TOPICAL CREAM [Youth Activating BB SPF30 Shade 3]


name: AMINO ACIDS, HAIR KERATIN 100 mg TOPICAL [kerasorb]


name: SODIUM CHLORIDE 4.5 mg in 0.5 mL SUBCUTANEOUS INJECTION [Diluent]


name: {24 (drospirenone 3 MG / ethinyl estradiol 0.02 MG Oral Tablet) / 4 (inert ingredients 1 MG Oral Tablet) } Pack [Jasmiel 28 Day]


name: {24 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) / 4 (ferrous fumarate 75 MG Oral Tablet) } Pack [Tarina 24 FE 1/20 28 Day]


name: Italian translation of the Medical Subject Headings, 2019


name: Medical Subject Headings Norwegian, 2019


name: Croatian translation of the Medical Subject Headings, 2019


name: Radiopharmaceutical Dosage Form Category


name: International Classification of Diseases, Eleventh Revision, Clinical Modification


name: CDISC Clinical Classification CDRS-R Test Name Terminology


name: CDISC Clinical Classification CDRS-R Test Code Terminology


name: CDISC Clinical Classification UHDRS 1999 Version Test Name Terminology


name: CDISC Clinical Classification UHDRS 1999 Version Test Code Terminology


name: CDISC Questionnaire FACIT-Dyspnea Scale 33 Item Bank Version Test Name Terminology


name: CDISC Questionnaire FACIT-Dyspnea Scale 33 Item Bank Version Test Code Terminology


name: CDISC Questionnaire FACT-BL Version 4 Test Name Terminology


name: CDISC Questionnaire FACT-BL Version 4 Test Code Terminology


name: CDISC Questionnaire NSCLC-SAQ Version 1.0 Test Name Terminology


name: CDISC Questionnaire NSCLC-SAQ Version 1.0 Test Code Terminology


name: CDISC Questionnaire SMDDS Version 1.0 Test Name Terminology


name: CDISC Questionnaire SMDDS Version 1.0 Test Code Terminology


name: UHDRS 1999 Version Clinical Classification Question


name: FACIT-Dyspnea Scale 33 Item Bank Version Questionnaire Question


name: FACT-BL Version 4 Questionnaire Question


name: NSCLC-SAQ Version 1.0 Questionnaire Question


name: SMDDS Version 1.0 Questionnaire Question


name: Adult Sickle Cell Quality of Life Measurement Information System


name: Hospital Consumer Assessment of Healthcare Providers and Systems


name: Telephonic Format with Interactive Voice Response Technology


name: Multihormonal Immunoreactivity Present in a Single Cell Type


name: Multihormonal Immunoreactivity Present in Two or More Cell Types


name: Two Separate Tumor Masses Present in the Same Organ


name: More Than Two Separate Tumor Masses Present in the Same Organ


name: Centers for Medicare and Medicaid Services System for Diagnosis-Related Groups


name: Medicare Severity Diagnosis-Related Groups


name: Period of Outpatient Prescription Drug Coverage for Enrollment Basis


name: Adherence Starts With Knowledge 12 Questionnaire


name: Forgot to Take Medicines Some of the Time Question


name: Run Out of Medicine Because Do Not Get Refills on Time Question


name: Taking Medicines More than Once a Day is Inconvenient Question


name: Feel Confident Each Medicine Will Help Question


name: Have Someone to Call with Questions about Medicines Question


name: Work Together with Doctor or Nurse to Make Decisions Question


name: Have Taken a Medicine More or Less Often than Prescribed Question


name: Have Skipped or Stopped Medicine Because Didn't Think it was Working Question


name: Have Skipped or Stopped Medicine Because it Made You Feel Bad Question


name: Have Skipped, Stopped, Not Refilled, or Taken Less Medicine Because of Cost Question


name: Did not Have Medicine When Time to Take it Question


name: 6-Channel Balloon Repositioning, Multichannel Applicator


name: Prior Invasive Malignancy of Other Sites


name: CDISC Protocol Entities Protocol Contact Role Response Terminology


name: CDISC Protocol Entities Study Contact Information Attribute Terminology


name: CDISC SEND Test Article Physical Substance Classification Response Terminology


name: CDISC SEND Planned Pharmacologic Target Mode of Action Response Terminology


name: CDISC SDTM Nutrition Findings About Test Code Terminology


name: CDISC SDTM Nutrition Findings About Test Name Terminology


name: CDISC SDTM Lung Cancer Findings About Test Code Terminology


name: Number of Electroencephalogram Electrodes


name: Continuous Surface ECG Recording for Non-human Species


name: Continuous ECG Recording for Non-human Species Using Implanted Leads


name: Erythroid Cells to Total Cells Ratio Measurement


name: Erythroid Cells to Nucleated Cells Ratio Measurement


name: Megakaryocytes to Leukocytes Ratio Measurement


name: HLA Class IC Histocompatibility Antigen Measurement


name: HLA DR Beta1 Histocompatibility Antigen Measurement


name: HLA DQ Beta1 Histocompatibility Antigen Measurement


name: Segmented and Band Form Neutrophils Measurement


name: Segmented, Band Form and Precursor Neutrophils Measurement


name: Inactive Glucagon-Like Peptide-1 Measurement


name: Fluorescence Lifetime Imaging Microscopy


name: Transitional Cell to Tumor Cell Ratio Measurement


name: European Consensus Score For Bone Marrow Fibrosis


name: Human Parainfluenza Type 1 Antigen Measurement


name: Total Clearance Predicted for Unbound Drug


name: Total Clearance Observed for Unbound Drug


name: Observed Area Under the Curve Infinity of Unbound Drug


name: Predicted Area Under the Curve Infinity of Unbound Drug


name: Area Under the Curve From Dosing to Last Concentration of Unbound Drug


name: Renal Clearance to Total Clearance Ratio Measurement After Oral Dosing


name: Renal Clearance to Total Clearance Ratio Measurement After Intravenous Dosing


name: Naive T Cell-Depleted Hematopoietic Stem Cell Transplantation


name: Neonatal Spontaneous Intestinal Perforation, Adverse Event


name: Neonatal Culture Positive Sepsis, Adverse Event


name: Neonatal Culture Negative Sepsis, Adverse Event


name: Neonatal Sinus Tachycardia, Adverse Event


name: Neonatal Sinus Bradycardia, Adverse Event


name: Neonatal Epileptic Seizure, Adverse Event


name: Neonatal Administration Site Complication, AE


name: Neonatal Respiratory Insufficiency, Adverse Event


name: Grade 1 Neonatal Intraventricular Hemorrhage, AE


name: Grade 3 Neonatal Intraventricular Hemorrhage, AE


name: Grade 4 Neonatal Intraventricular Hemorrhage, AE


name: Grade 5 Neonatal Intraventricular Hemorrhage, AE


name: Grade 1 Hypoxic Ischemic Encephalopathy, AE


name: Grade 2 Hypoxic Ischemic Encephalopathy, AE


name: Grade 3 Hypoxic Ischemic Encephalopathy, AE


name: Grade 4 Hypoxic Ischemic Encephalopathy, AE


name: Grade 5 Hypoxic Ischemic Encephalopathy, AE


name: Grade 1 Periventricular Leukomalacia, AE


name: Grade 2 Periventricular Leukomalacia, AE


name: Grade 3 Periventricular Leukomalacia, AE


name: Grade 1 Neonatal Coagulation Disorder, AE


name: Grade 2 Neonatal Coagulation Disorder, AE


name: Grade 3 Neonatal Coagulation Disorder, AE


name: Grade 4 Neonatal Coagulation Disorder, AE


name: Grade 5 Neonatal Coagulation Disorder, AE


name: Grade 1 Neonatal Respiratory Insufficiency, AE


name: Grade 2 Neonatal Respiratory Insufficiency, AE


name: Grade 3 Neonatal Respiratory Insufficiency, AE


name: Grade 4 Neonatal Respiratory Insufficiency, AE


name: Grade 5 Neonatal Respiratory Insufficiency, AE


name: Grade 1 Neonatal Respiratory Distress Syndrome, AE


name: Grade 2 Neonatal Respiratory Distress Syndrome, AE


name: Grade 3 Neonatal Respiratory Distress Syndrome, AE


name: Grade 4 Neonatal Respiratory Distress Syndrome, AE


name: Grade 5 Neonatal Respiratory Distress Syndrome, AE


name: Grade 1 Neonatal Pulmonary Hemorrhage, AE


name: Grade 2 Neonatal Pulmonary Hemorrhage, AE


name: Grade 3 Neonatal Pulmonary Hemorrhage, AE


name: Grade 4 Neonatal Pulmonary Hemorrhage, AE


name: Grade 5 Neonatal Pulmonary Hemorrhage, AE


name: Grade 1 Persistent Pulmonary Hypertension of the Newborn, AE


name: Grade 2 Persistent Pulmonary Hypertension of the Newborn, AE


name: Grade 3 Persistent Pulmonary Hypertension of the Newborn, AE


name: Grade 4 Persistent Pulmonary Hypertension of the Newborn, AE


name: Grade 5 Persistent Pulmonary Hypertension of the Newborn, AE


name: Grade 1 Neonatal Gastrointestinal Bleeding, AE


name: Grade 2 Neonatal Gastrointestinal Bleeding, AE


name: Grade 3 Neonatal Gastrointestinal Bleeding, AE


name: Grade 4 Neonatal Gastrointestinal Bleeding, AE


name: Grade 5 Neonatal Gastrointestinal Bleeding, AE


name: Grade 3 Neonatal Spontaneous Intestinal Perforation, AE


name: Grade 4 Neonatal Spontaneous Intestinal Perforation, AE


name: Grade 5 Neonatal Spontaneous Intestinal Perforation, AE


name: Grade 2 Neonatal Culture Negative Sepsis, AE


name: Grade 3 Neonatal Culture Negative Sepsis, AE


name: Grade 4 Neonatal Culture Negative Sepsis, AE


name: Grade 5 Neonatal Culture Negative Sepsis, AE


name: Grade 2 Neonatal Culture Positive Sepsis, AE


name: Grade 3 Neonatal Culture Positive Sepsis, AE


name: Grade 4 Neonatal Culture Positive Sepsis, AE


name: Grade 5 Neonatal Culture Positive Sepsis, AE


name: Grade 1 Neonatal Administration Site Complication, AE


name: Grade 2 Neonatal Administration Site Complication, AE


name: Grade 3 Neonatal Administration Site Complication, AE


name: Grade 4 Neonatal Administration Site Complication, AE


name: Grade 5 Neonatal Administration Site Complication, AE


name: Blasts 5-9 Percent of Bone Marrow Nucleated Cells


name: Blasts 2-4 Percent of Peripheral Blood White Cells


name: Children's Depression Rating Scale, Revised Clinical Classification


name: Unified Huntington's Disease Rating Scale 1999 Version Clinical Classification


name: Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank Questionnaire


name: Functional Assessment of Cancer Therapy-Bladder Version 4 Questionnaire


name: Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0


name: Symptoms of Major Depressive Disorder Scale v1.0 Questionnaire


name: CDRS-R - Depressed Facial Affect Comment


name: UHDRS 1999 Version - Ocular Pursuit: Horizontal


name: UHDRS 1999 Version - Ocular Pursuit: Vertical


name: UHDRS 1999 Version - Saccade Initiation: Horizontal


name: UHDRS 1999 Version - Saccade Initiation: Vertical


name: UHDRS 1999 Version - Saccade Velocity: Horizontal


name: UHDRS 1999 Version - Saccade Velocity: Vertical


name: UHDRS 1999 Version - Pronate/Supinate: Hands: Right


name: UHDRS 1999 Version - Pronate/Supinate: Hands: Left


name: UHDRS 1999 Version - Rigidity: Arms: Right


name: UHDRS 1999 Version - Rigidity: Arms: Left


name: UHDRS 1999 Version - Maximal Dystonia: RUE


name: UHDRS 1999 Version - Maximal Dystonia: LUE


name: UHDRS 1999 Version - Maximal Dystonia: RLE


name: UHDRS 1999 Version - Maximal Dystonia: LLE


name: UHDRS 1999 Version - Maximal Chorea: Face


name: UHDRS 1999 Version - Maximal Chorea: BOL


name: UHDRS 1999 Version - Maximal Chorea: Trunk


name: UHDRS 1999 Version - Maximal Chorea: RUE


name: UHDRS 1999 Version - Maximal Chorea: LUE


name: UHDRS 1999 Version - Maximal Chorea: RLE


name: UHDRS 1999 Version - Maximal Chorea: LLE


name: UHDRS 1999 Version - Retropulsion Pull Test


name: UHDRS 1999 Version - Diagnosis Confidence Level


name: UHDRS 1999 Version - Verbal Fluency Test


name: UHDRS 1999 Version - Symbol Digit Modalities Test


name: UHDRS 1999 Version - Depressed Mood: Frequency


name: UHDRS 1999 Version - Depressed Mood: Severity


name: UHDRS 1999 Version - Self-esteem/Guilt: Frequency


name: UHDRS 1999 Version - Self-esteem/Guilt: Severity


name: UHDRS 1999 Version - Suicidal Thoughts: Frequency


name: UHDRS 1999 Version - Suicidal Thoughts: Severity


name: UHDRS 1999 Version - Irritable Behavior: Frequency


name: UHDRS 1999 Version - Irritable Behavior: Severity


name: UHDRS 1999 Version - Disruptive Behavior: Frequency


name: UHDRS 1999 Version - UDHR1-Disruptive Behavior: Severity


name: UHDRS 1999 Version - Perseverative Thinking: Frequency


name: UHDRS 1999 Version - UDHR1-Perseverative Thinking: Severity


name: UHDRS 1999 Version - Compulsive Behavior: Frequency


name: UHDRS 1999 Version - UDHR1-Compulsive Behavior: Severity


name: UHDRS 1999 Version - Delusions: Frequency


name: UHDRS 1999 Version - UDHR1-Delusions: Severity


name: UHDRS 1999 Version - Hallucinations: Frequency


name: UHDRS 1999 Version - UDHR1-Hallucinations: Severity


name: UHDRS 1999 Version - UDHR1-Examiner Believe Subject Confused


name: UHDRS 1999 Version - UDHR1-Examiner Believe Signs of Dementia


name: UHDRS 1999 Version - UDHR1-Dementia Altered Performance


name: UHDRS 1999 Version - UDHR1-Examiner Believe Signs Depression


name: UHDRS 1999 Version - Pharmacotherapy of Depression


name: UHDRS 1999 Version - Pharmacotherapy of Irritability


name: UHDRS 1999 Version - Behavior Assessment Obtained From


name: UHDRS 1999 Version - Gainful Employment Accustomed Work


name: UHDRS 1999 Version - Any Gainful Employment


name: UHDRS 1999 Version - Volunteer or Non Gainful Work


name: UHDRS 1999 Version - Manage Finances Without Help


name: UHDRS 1999 Version - Shop for Groceries Without Help


name: UHDRS 1999 Version - Handle Money as Purchaser


name: UHDRS 1999 Version - Supervise Children Without Help


name: UHDRS 1999 Version - Operate Automobile Safely


name: UHDRS 1999 Version - Do Housework Without Help


name: UHDRS 1999 Version - Do Laundry Without Help


name: UHDRS 1999 Version - Prepare Own Meals Without Help


name: UHDRS 1999 Version - Use Telephone Without Help


name: UHDRS 1999 Version - Take Medications Without Help


name: UHDRS 1999 Version - Feed Himself/Herself Without Help


name: UHDRS 1999 Version - Dress Himself/Herself Without Help


name: UHDRS 1999 Version - Bathe Himself/Herself Without Help


name: UHDRS 1999 Version - Public Transportation Without Help


name: UHDRS 1999 Version - Walk Own Neighborhood Without Help


name: UHDRS 1999 Version - Walk Without Falling


name: UHDRS 1999 Version - Comb Hair Without Help


name: UHDRS 1999 Version - Transfer Chair Without Help


name: UHDRS 1999 Version - Get in and Out of Bed Without Help


name: UHDRS 1999 Version - Use Toilet/Commode Without Help


name: UHDRS 1999 Version - Care Provided at Home


name: UHDRS 1999 Version - Functional Assess Obtained From


name: UHDRS 1999 Version - Current Level Subject Independence


name: UHDRS 1999 Version - Functional Capacity Obtained From


name: UHDRS 1999 Version - Purpose of This Visit


name: UHDRS 1999 Version - Since Last Assessment Opinion


name: UHDRS 1999 Version - Believe Subject Has Manifest HD


name: UHDRS 1999 Version - Permanently Institutionalized


name: UHDRS 1999 Version - Continue to Be Assessed for Study


name: UHDRS 1999 Version - Total Behavior Score


name: UHDRS 1999 Version - Mood Subscale Score


name: UHDRS 1999 Version - Behavior Subscale Score


name: UHDRS 1999 Version - Psychosis Subscale Score


name: UHDRS 1999 Version - Obsessive Subscale Score


name: UHDRS 1999 Version - Total Functional Capacity Score


name: UHDRS 1999 Version - Independence Scale Score


name: UHDRS 1999 Version - Functional Checklist Score


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Dressing Without Help


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Dressing Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk 50 Steps


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk 50 Steps Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk Up 20 Stairs


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk Up 20 Stairs Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Preparing Meals


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Preparing Meals Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Washing Dishes


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Washing Dishes Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Sweeping/Mopping


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Sweeping/Mopping Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Making a Bed


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Making a Bed Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lifting 10-20 Lbs


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lifting 10-20 Lbs Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carry 10-20 Lbs


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carry 10-20 Lbs Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk for 1/2 Mile


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk for 1/2 Mile Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Bath Without Help


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Bath Without Help Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Taking a Shower


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Taking a Shower Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Putting on Socks


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Putting on Socks Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Standing 5 Minutes


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Standing 5 Minutes Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking 10 Steps


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking 10 Steps Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking 1/2 Mile


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking 1/2 Mile Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 5 Stairs


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 5 Stairs Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 10 Stairs


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 10 Stairs Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 30 Stairs


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 30 Stairs Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lift Less Than 5 Lbs


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lift Less Than 5 Lbs Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lifting 5-10 Lbs


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lifting 5-10 Lbs Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lift More Than 20 Lbs


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lift More Than 20 Lbs Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carrying Less Than 5 Lbs


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carrying Less Than 5 Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carrying 5-10 Lbs


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carrying 5-10 Lbs Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Get In/Out of a Car


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Get In/Out of a Car Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Dining Out


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Dining Out Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Low-intensity Activity


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Low-intensity Activity Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Moderate Activity


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Moderate Activity Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk Fast 50 Steps


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk Fast 50 Steps Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Fast 1 Mile


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Fast 1 Mile Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Singing or Humming


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Singing or Humming Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Talking While Walking


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Talking While Walk Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Scrubbing the Floor


name: FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Scrubbing the Floor Why Not


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Dressing Without Help


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walk 50 Steps


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walk Up 20 Stairs


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Preparing Meals


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Washing Dishes


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Sweeping/Mopping


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Making a Bed


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Lifting 10-20 Lbs


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Carry 10-20 Lbs


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walk for 1/2 Mile


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Taking a Bath Without Help


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Taking a Shower


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Putting on Socks


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Standing 5 Minutes


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking 10 Steps


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking 1/2 Mile


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking Up 5 Stairs


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking Up 10 Stairs


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking Up 30 Stairs


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Scrubbing the Floor


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Lifting Less Than 5 Lbs


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Lifting 5-10 Lbs


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Lifting More Than 20 Lbs


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Carrying Less Than 5 Lbs


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Carrying 5-10 Lbs


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Get In/Out of a Car


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Dining Out


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Low-intensity Activity


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Moderate Activity


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walk Fast 50 Steps


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking Fast 1 Mile


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Singing or Humming


name: FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Talking While Walking


name: FACT-BL Version 4 - I Have a Lack of Energy


name: FACT-BL Version 4 - Trouble Meeting Needs of Family


name: FACT-BL Version 4 - Bothered by Treatment Side Effect


name: FACT-BL Version 4 - I Am Forced to Spend Time in Bed


name: FACT-BL Version 4 - I Feel Close to My Friends


name: FACT-BL Version 4 - Get Emotional Support From Family


name: FACT-BL Version 4 - I Get Support From My Friends


name: FACT-BL Version 4 - My Family Has Accepted My Illness


name: FACT-BL Version 4 - Satisfied Communication Illness


name: FACT-BL Version 4 - I Feel Close to My Partner


name: FACT-BL Version 4 - I Am Satisfied With My Sex Life


name: FACT-BL Version 4 - Satisfied With How I Am Coping


name: FACT-BL Version 4 - Losing Hope Against Illness


name: FACT-BL Version 4 - Worry My Condition Will Get Worse


name: FACT-BL Version 4 - My Work Is Fulfilling


name: FACT-BL Version 4 - I Am Able to Enjoy Life


name: FACT-BL Version 4 - I Have Accepted My Illness


name: FACT-BL Version 4 - Enjoy Things I Usually Do for Fun


name: FACT-BL Version 4 - Content With Quality of My Life


name: FACT-BL Version 4 - Trouble Controlling My Urine


name: FACT-BL Version 4 - I Have Control of My Bowels


name: FACT-BL Version 4 - I Urinate More Frequently


name: FACT-BL Version 4 - I Have a Good Appetite


name: FACT-BL Version 4 - I Like the Appearance of My Body


name: FACT-BL Version 4 - It Burns When I Urinate


name: FACT-BL Version 4 - I Am Interested in Sex


name: FACT-BL Version 4 - Able to Have/Maintain Erection


name: FACT-BL Version 4 - Do You Have an Ostomy Appliance


name: FACT-BL Version 4 - Embarrassed by Ostomy Appliance


name: FACT-BL Version 4 - Caring for Ostomy Appliance Is Difficult


name: NSCLC-SAQ Version 1.0 - Rate Coughing at Worst


name: NSCLC-SAQ Version 1.0 - Rate Worst Pain in Chest


name: NSCLC-SAQ Version 1.0 - Rate Worst Pain Other Than Chest


name: NSCLC-SAQ Version 1.0 - Short of Breath Usual Activities


name: NSCLC-SAQ Version 1.0 - How Often Low Energy


name: NSCLC-SAQ Version 1.0 - How Often Tire Easily


name: NSCLC-SAQ Version 1.0 - How Often Poor Appetite


name: SMDDS Version 1.0 - How Sad Have You Felt


name: SMDDS Version 1.0 - How Hopeless Have You Felt


name: SMDDS Version 1.0 - How Irritable Have You Felt


name: SMDDS Version 1.0 - How Overwhelmed Have You Felt


name: SMDDS Version 1.0 - How Worried Have You Felt


name: SMDDS Version 1.0 - How Tired Have You Felt


name: SMDDS Version 1.0 - How Difficult Stop Think Problems


name: SMDDS Version 1.0 - How Difficult to Concentrate


name: SMDDS Version 1.0 - How Difficult to Enjoy Daily Life


name: SMDDS Version 1.0 - How Often Problem With Sleep


name: SMDDS Version 1.0 - How Often Have Poor Appetite


name: SMDDS Version 1.0 - How Often Did You Over Eat


name: SMDDS Version 1.0 - How Much Feel Like Doing Nothing


name: SMDDS Version 1.0 - How Much Blame Yourself Bad Thing


name: SMDDS Version 1.0 - How Much Feel Not Worth Living


name: Linear Energy Transfer-Optimized Intensity Modulated Proton Therapy


name: Hematopoietic Cell Transplantation-Comorbidity Index


name: International Metastatic Renal Cell Carcinoma Database Consortium Criteria


name: Able to Remove a Heavy Suitcase Question


name: Ultrasound-Guided Transbronchial Needle-Delivered Interstitial Photodynamic Therapy


name: Gardasil Immunogenicity with Needle-Free Injection


name: Diode Laser Fiber Type Selective Stimulator


name: Well Differentiated Neuroendocrine Lesion


name: Intermediate Grade Neuroendocrine Lesion


name: Poorly Differentiated Neuroendocrine Lesion


name: MD Anderson Symptom Inventory - Gastrointestinal


name: Diarrhea or Watery Stools via Stoma at its Worst Question


name: Sore Mouth or Throat at its Worst Question


name: Bone Marrow Lymphoplasmacytic Infiltrate


name: Diagnostic Fiberoptic Endoscopic Examination


name: Cornell Scale for Depression in Dementia


name: Modified Ryan Scheme for Tumor Regression


name: Cytoplasmic Accumulation of Black Pigment


name: Blasts 2 Percent or More of Peripheral Blood White Cells


name: Myeloblasts More than 5 Percent of Bone Marrow Nucleated Cells


name: Testosterone Less than or Equal to 100 ng/dL


name: M1 Macrophage to M2 Macrophage Ratio Measurement


name: FLT3 Tyrosine Kinase Domain Mutation Negative


name: Problems With Thinking or Remembering Things Question


name: Hurt or Pain Other Than Headache Question


name: Throwing Up or Feeling Like May Throw Up Question


name: Feeling More or Less Hungry Than Usual Question


name: Other Things That Have Bothered Lately Question


name: Ability to See Well Enough to Read Ordinary Newsprint Question


name: Ability to See Well Enough to Recognize Friend on Other Side of Street Question


name: Ability to Hear What Was Said in Group Conversation with at Least Three Other People Question


name: Ability to Hear What Was Said in Conversation with One Other Person in Quiet Room Question


name: Ability to be Understood When Speaking Own Language with People Who do not Know the Subject Question


name: Ability to be Understood When Speaking with People Who Know the Subject Well Question


name: Ability to Use Hands and Fingers Question


name: Ability to Think and Solve Day-to-day Problems Question


name: Ability to Perform Basic Activities Question


name: Able to See Well Enough without Correction


name: Unable to See Well Enough even with Correction


name: Unable to Hear, but did not Wear Hearing Aids


name: Curcumin/Chondroitin Sulfate/Hyaluronic Acid/Quercetin Soft Gels


name: Mild to Moderate Pain or Discomfort that Did Not Prevent Activities


name: Moderate Pain or Discomfort that Prevented Some Activities


name: Moderate to Severe Pain or Discomfort that Prevented Some Activities


name: Severe Pain or Discomfort that Prevented Most Activities


name: Able to Walk Around Neighborhood Without Difficulty; No Walking Equipment Needed


name: Able to Walk Around Neighborhood with Difficulty; No Walking Equipment or Help Required


name: Able to Walk Around Neighborhood with Walking Equipment; No Help Required


name: Able to Walk Only Short Distances with Walking Equipment; Required a Wheelchair to Get Around the Neighborhood


name: Unable to Walk Alone, Even with Walking Equipment; Able to Walk Short Distances with Help; Require Wheelchair to Get Around the Neighborhood


name: Limitations in Use of Hands or Fingers; Requires Special Tools for Independence


name: Limitations in Use of Hands or Fingers; Requires Help for Some Tasks


name: Limitations in Use of Hands or Fingers; Requires Help for Most Tasks


name: Limitations in Use of Hands or Fingers; Requires Help for All Tasks


name: Able to Think Clearly and Solve Day-to-day Problems


name: Had a Little Difficulty When Trying to Think and Solve Day-to-day Problems


name: Had Some Difficulty When Trying to Think and Solve Day-to-day Problems


name: Had Great Difficulty When Trying to Think and Solve Day-to-day Problems


name: Unable to Think or Solve Day-to-day Problems


name: Eat, Bathe, Dress, and Use Toilet Normally


name: Eat, Bathe, Dress, and Use Toilet with Difficulty


name: Required Mechanical Equipment to Eat, Bathe, Dress, or Use Toilet Independently


name: Required Help to Eat, Bathe, Dress, or Use Toilet


name: Occasionally Fretful, Angry, Irritable, Anxious, or Depressed


name: Often Fretful, Angry, Irritable, Anxious, or Depressed


name: Almost Always Fretful, Angry, Irritable, Anxious, or Depressed


name: Extremely Fretful, Angry, Irritable, Anxious, or Depressed; Needing Professional Help


name: Occasional Pain or Discomfort; Relief from Non-prescription Drugs or Activity; No Disruption of Normal Activities


name: Frequent Pain or Discomfort; Relief from Oral Medicines; Occasional Disruption of Normal Activities


name: Frequent Pain or Discomfort; Relief Requires Prescription Narcotics; Frequent Disruption of Normal Activities


name: Severe Pain or Discomfort; Pain not Relieved by Drugs; Constant Disruption of Normal Activities


name: PROMIS Pediatric and Parent Proxy Physical Health Domain


name: Being Tired Made it Hard to Keep up with Schoolwork Question


name: Being Tired Made it Hard to Play or Go Out with Friends as Much as Would Like Question


name: Hard to Pay Attention Because of Tiredness Question


name: Too Tired for Sports or Exercise Question


name: Too Tired to Enjoy the Things I Like to Do Question


name: No Evidence of Tumor Cell Necrosis Present


name: Regimen Used to Treat Malignant Neuroendocrine and Adrenal Neoplasm


name: Lymphoblasts More Than 50 Percent of Bone Marrow Nucleated Cells


name: Neoplastic Plasma Cells 5 Percent or Less of Bone Marrow Nucleated Cells


name: Lymphoblasts 5 Percent or More of Peripheral Blood White Cells


name: Ginseng/Lingzhi Mushroom/Cordyceps sinensis/Rose Oral Liquid


name: Milligram Iron per Gram Liver (Dry Weight)


name: Loss of Immunohistochemical Expression of Succinate Dehydrogenase (SDH) B


name: Measurement of free immunoglobulin light chain


name: Chemokine (C-C Motif) Ligand 2 Excretion Rate


name: Phosphorylated STAT3 to STAT3 Ratio Measurement


name: TNF Superfamily Member 12 Excretion Rate


name: Soluble TNF Superfamily Member 12 Measurement


name: Intact Epithelial Reticular Basement Membrane Length to Total Epithelial Reticular Basement Membrane Length Ratio Measurement


name: Susceptibility Score Mutations Indicator


name: N1 Sleep to Total Sleep Time Ratio Measurement


name: N2 Sleep to Total Sleep Time Ratio Measurement


name: N3 Sleep to Total Sleep Time Ratio Measurement


name: REM to Total Sleep Time Ratio Measurement


name: Metabolite Ratio for AUC Infinity Observed


name: Metabolite Ratio for AUC Infinity Predicted


name: Metabolite Ratio AUC Last Nonzero Concentration


name: Metabolite Ratio for AUC Dosing Interval


name: Metabolite Ratio for Maximum Concentration


name: Volume of Distribution Steady State Observed by Fraction of Dose Absorbed


name: Volume of Distribution Steady State Predicted by Fraction of Dose Absorbed


name: Volume of Distribution Steady State Observed by Unbound Drug


name: Volume of Distribution Steady State Predicted by Unbound Drug


name: Volume of Distribution Steady State Observed by Bound Drug


name: Volume of Distribution Steady State Predicted by Bound Drug


name: Area Under the Curve Ratio Infinity Predicted


name: Area Under the Curve Ratio Infinity Observed


name: Observed Volume of Distribution of Absorbed Fraction for Unbound Drug


name: Open Label for Treatment And Double Blind to Dose


name: CDISC Therapeutic Area User Guide Name and Version


name: FDA Technical Specification Name and Version


name: Study Data Tabulation Model Implementation Guide Version


name: SEND Developmental and Reproductive Toxicology Implementation Guide Version 1.1


name: Authorized Investigational Medicinal Product


name: Attributable, Legible, Contemporaneous, Original, Accurate


name: Attributable, Legible, Contemporaneous, Original, Accurate Plus


name: Clinical Outcome Assessment Content Validation


name: Clinical Outcome Assessment Construct Validation


name: Clinical Outcome Assessment Criterion Validation


name: ADROIT Electronically Generated Information Service


name: Regional Health Information Organization


name: Blasts More than 15 Percent of Bone Marrow Nucleated Cells


name: CDISC Clinical Classification COVI Test Name Terminology


name: CDISC Clinical Classification COVI Test Code Terminology


name: Covi Anxiety Scale Clinical Classification


name: Blasts 25 Percent or Less of Bone Marrow Nucleated Cells


name: Neoplastic Plasma Cells 10-59 Percent of Bone Marrow Nucleated Cells


name: Prior Radiation Therapy of Affected Breast


name: Prior Systemic Chemotherapy for Current Cancer


name: Prior Systemic Therapy for Current Cancer


name: Radiation to Greater than 25 Percent of Bone Marrow


name: Medical Record Documentation about this History of Cancer Treatment Question


name: Alcohol Consumption Equal to or Less than 2 Drinks per Day for Men and 1 Drink or Less per Day for Women


name: Alcohol Consumption More than 2 Drinks per Day for Men and More than 1 Drink per Day for Women


name: Current non-drinker with Past Alcohol Consumption


name: Number of Years When Consumed More than 2 Drinks per Day for Men and More than 1 Drink per Day for Women


name: Lifelong non-smoker Less than 100 cigarettes smoked in lifetime


name: Current Smoker Includes Daily and Non-daily Smokers


name: Current Reformed Smoker, More than 15 Years


name: Current Reformed Smoker Within Past 15 Years


name: When Participant Smoked, How many Cigarettes Smoked


name: Secondhand Smoke Exposure in Household during Childhood


name: Secondhand Smoke Exposure in Current Household


name: Secondhand Smoke Exposure History Not Available


name: New Tumor Event After Initial Treatment Present


name: Type of New Tumor Event (Check all that apply) Question


name: Specify Site of New Tumor Event Question


name: Number of Days from Date of Initial Cancer Diagnosis to Date of New Tumor Event after Initial Treatment


name: Number of Days from Date of Initial Pathologic Diagnosis to Date of Additional Surgery for New Tumor Event


name: Was Additional Surgery for New Tumor Event Performed Question


name: Date of Additional Surgery for New Tumor Event Question


name: Number of Days from Date of Initial Cancer Diagnosis to Date of Additional Surgery for New Tumor Event


name: Fractionated dose stereotactic radiation therapy


name: HER2/Neu Expression by Validated Immunohistochemistry


name: HER2/Neu Status by Validated Single-probe in Situ Hybridization


name: HER2/Neu Status by Validated Dual-probe in Situ Hybridization


name: Tumor Status at Date of Last Contact or Death


name: Number of Days from Date of Initial Cancer Diagnosis to Date of Death


name: Number of Days from Date of Initial Cancer Diagnosis to Date of Last Contact


name: CPTAC Baseline Medical Forms Terminology


name: CHAMPS Activities Questionnaire for Older Adults


name: Attend Other Club or Group Meetings Question


name: Play Golf and Carry Own Equipment Question


name: Ride a Bicycle or Stationary Bike Question


name: Do Water Exercises Other than Swimming Question


name: Do Stretching or Flexibility Exercises Question


name: Do Moderate to Heavy Strength Training Question


name: Do General Conditioning Exercises Question


name: Play Basketball, Soccer, or Racquetball Question


name: When Help is Needed Can Count on Someone Willing and Able to Meet Needs Question


name: Use Five or More Different Prescription Medications Regularly Question


name: Sometimes Forget to Take Prescription Medications Question


name: Have Recently Lost Weight and Clothing Has Become Looser Question


name: Greater Than Twenty Seconds Walking, or Patient Unwilling, or Requires Assistance Walking


name: CDISC SDTM Lung Cancer Findings About Test Name Terminology


name: Anti-Double Stranded DNA IgG Measurement


name: Grade 1 Neonatal Culture Positive Sepsis, AE


name: UHDRS 1999 Version - Maximal Dystonia: Trunk


name: UHDRS 1999 Version - UDHR1-Confusion Altered Performance


name: UHDRS 1999 Version - Since Last Assessment Feel


name: SMDDS Version 1.0 - How Much Push Yourself Do Things


name: Changes in How Body or Face Looks Question


name: International System for Human Cytogenetic Nomenclature


name: Fermented Prebiotic Dietary Supplement AferBio


name: Attend Concert, Movie, Lecture or Sport Event Question


name: OCTINOXATE 5.5 g in 100 g / OCTOCRYLENE 2 g in 100 g / OXYBENZONE 3.5 g in 100 g TOPICAL LIPSTICK [LypSyl Honeyberry]


name: PYRIDOXINE 50 mg / NIACIN 50 mg / CYANOCOBALAMIN 0.03 mg / Vitamin A 50 mg ORAL CAPSULE [Lutime]


name: AVOBENZONE 28.5 mg in 1 mL / HOMOSALATE 50 mg in 1 mL / OCTINOXATE 70 mg in 1 mL / OCTISALATE 30 mg in 1 mL / OCTOCRYLENE 90 mg in 1 mL TOPICAL CREAM [HYDRA BEAUTE SPF 15]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 15 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 10 g in 100 g TOPICAL AEROSOL, SPRAY


name: OCTINOXATE 30 mg in 1 mL / TITANIUM DIOXIDE 17.5 mg in 1 mL TOPICAL EMULSION [FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration 2WP]


name: HOMOSALATE 90 mg in 1 g / OCTISALATE 40 mg in 1 g / AVOBENZONE 30 mg in 1 g / OCTOCRYLENE 70 mg in 1 g TOPICAL LOTION [Avail Facial Sunscreen SPF 25]


name: TITANIUM DIOXIDE 1870 mg in 50 mL / ZINC OXIDE 7128 mg in 50 mL TOPICAL CREAM [bareMinerals Skinlongevity Vital Power Moisturizer Broad Spectrum SPF 30]


name: potassium ascorbate, potassium bicarbonate


name: GoodSense 6-Bevel 31G 1/4 inch Pen Needle


name: GoodSense 6-Bevel 31G 5/16 inch Pen Needle


name: Easy Touch 29G 3/16 inch Safety Pen Needle


name: Easy Touch 29G 5/16 inch Safety Pen Needle


name: OCTINOXATE 0.075 g in 1 g / TITANIUM DIOXIDE 0.042 g in 1 g / ZINC OXIDE 0.07 g in 1 g TOPICAL CREAM [MISSHA M Perfect Cover BB SPF42 No21]


name: SENSI-CARE STING-FREE BARRIER WIPE C#413501


name: DRESSING,MEPILEX BORDER 6.3IN X 7.9IN #282055


name: CONTACT LENS CONDITIONING (BOSTON ADVANCE) SOLN


name: TITANIUM DIOXIDE 84 mg in 1 mL / ZINC OXIDE 98 mg in 1 mL / ENSULIZOLE 20 mg in 1 mL / OCTINOXATE 55 mg in 1 mL / OXYBENZONE 5 mg in 1 mL TOPICAL CREAM [Artistry Ideal Radiance Illuminating CC SPF 50 Broad Spectrum Sunscreen Deep]


name: ZINC OXIDE 80 mg in 1 g TOPICAL LIPSTICK [Mineral Sunscreen Lip Balm SPF 15]


name: Medical Food Oral Powder for Suspension [Tylactin Build]


name: Medical Food Oral Suspension [Glytactin RTD Lite 15]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 7 g in 100 mL TOPICAL JELLY [Brightening Daily Protector Broad Spectrum SPF 30]


name: AVOBENZONE 30 mg in 1 mL / OCTINOXATE 75 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OXYBENZONE 40 mg in 1 mL TOPICAL LOTION [EXTRASHADE Daily Defense Hydrating Sunscreen SPF 30]


name: BANDAGE TUBULAR ELASTIC 5IN X 11YD SAG13120


name: Neonatal TPN Starter, Amino Acids 2.5% with 10% Dextrose and Calcium Gluconate intravenous solution


name: parenteral nutrition solution w/electrolytes Amino Acids 2.5% with 10% Dextrose and Calcium Gluconate intravenous solution


name: SimplyThick EasyMix Mildly Thick Instant Food Thickener Gel Packets


name: SimplyThick EasyMix Moderately Thick Instant Food Thickener Gel Packets


name: AMBROXOL HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: ASPARAGINASE 79.2 g in 80 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: ATOVAQUONE 1 g in 1 g NOT APPLICABLE POWDER


name: CEFADROXIL 1 g in 1 g NOT APPLICABLE POWDER


name: CEFTIOFUR 1 kg in 1 kg NOT APPLICABLE POWDER


name: CISAPRIDE MONOHYDRATE 24.75 kg in 25 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: CISAPRIDE MONOHYDRATE 25 g in 25 g NOT APPLICABLE POWDER


name: DESMOPRESSIN ACETATE 0.99 g in 1 g NOT APPLICABLE POWDER [Desmopressin Acetate]


name: DETOMIDINE HYDROCHLORIDE 1 kg in 1 kg NOT APPLICABLE POWDER


name: GABAPENTIN 1 g in 1 g NOT APPLICABLE POWDER


name: ISOTRETINOIN 1 g in 1 g NOT APPLICABLE POWDER


name: LEVETIRACETAM 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: Medroxyprogesterone Acetate 1 kg in 1 kg NOT APPLICABLE POWDER


name: NITENPYRAM 1 g in 1 g NOT APPLICABLE POWDER


name: PAROMOMYCIN SULFATE 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: PREGABALIN .99 kg in 1 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: PYRIMETHAMINE 24.75 kg in 25 kg NOT APPLICABLE POWDER [Pyrimethamine]


name: SEVELAMER CARBONATE 1 kg in 1 kg NOT APPLICABLE POWDER


name: VIDARABINE 1 g in 1 g NOT APPLICABLE POWDER


name: DROMETRIZOLE TRISILOXANE 40 mg in 1 mL / TITANIUM DIOXIDE 40 mg in 1 mL / ECAMSULE 120 mg in 1 mL / BEMOTRIZINOL 5 mg in 1 mL / DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE 5 mg in 1 mL / OCTINOXATE 67.5 mg in 1 mL TOPICAL LOTION [KIEHLS DERMATOLOGIST SOLUTIONS ULTRA LIGHT DAILY UV DEFENSE SUNSCREEN SPF 50 HIGH PROTECTION ANTI-POLLUTION LIGHTWEIGHT FORMULA FOR ALL SKIN TYPES]


name: OCTINOXATE 5 g in 100 g / TITANIUM DIOXIDE 2 g in 100 g TOPICAL PASTE [STUDIO FINISH CONCEALER BROAD SPECTRUM SPF 35]


name: AVOBENZONE 3 g in 100 g / OCTINOXATE 7.5 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 2.7 g in 100 g / OXYBENZONE 4 g in 100 g TOPICAL CREAM [Advanced Anti-Wrinkle Therapy Cicatricure]


name: HOMOSALATE 107 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL / OXYBENZONE 39 mg in 1 mL / OCTISALATE 32 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / DROMETRIZOLE TRISILOXANE 5 mg in 1 mL TOPICAL LOTION [Garnier Ombrelle SPF 60 UVA UVB Kids Wet N Protect Sunscreen Protection Even on Wet Skin Hypoallergenic Water/sweat resistant 80 minutes Quick Absorption]


name: Homosalate 3.80 g in 40 mL / Octocrylene 2.00 g in 40 mL / Octisalate 1.80 g in 40 mL / Avobenzone 1.20 g in 40 mL TOPICAL CREAM [Moonshot Multi Protection UV Bouncer]


name: homosalate 150 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL / OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / DROMETRIZOLE TRISILOXANE 5 mg in 1 mL TOPICAL LOTION [Garnier Ombrelle SPF 60 Complete UVA UVB Sensitive Advanced Sunscreen for Sensitive Skin Hypoallergenic Non comedogenic Quick Absorption Water/sweat resistant 80 minutes]


name: homosalate 70 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL / OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / DROMETRIZOLE TRISILOXANE 5 mg in 1 mL TOPICAL LOTION [Garnier Ombrelle SPF 30 Complete UVA UVB Sensitive Advanced Sunscreen for Sensitive Skin Hypoallergenic Non comedogenic Quick Absorption Water/sweat resistant 80 minutes]


name: PAROMOMYCIN SULFATE 1 g in 1 g NOT APPLICABLE POWDER


name: AVOBENZONE 3 g in 100 g / OXYBENZONE 6 g in 100 g / OCTOCRYLENE 10 g in 100 g TOPICAL CREAM [Scar Cream SPF 30]


name: Outpatient occupational therapy services furnished in whole or in part by an occupational therapy assistant


name: Outpatient physical therapy services furnished in whole or in part by a physical therapist assistant


name: Items and services furnished by a provider-based, off-campus emergency department


name: Telehealth services for diagnosis, evaluation, or treatment, of symptoms of an acute stroke


name: Prescribed amounts of stationary oxygen for daytime use while at rest and nighttime use differ and the average of the two amounts is less than 1 liter per minute (lpm)


name: Prescribed amounts of stationary oxygen for daytime use while at rest and nighttime use differ and the average of the two amounts exceeds 4 liters per minute (lpm) and portable oxygen is prescribed


name: Prescribed amounts of stationary oxygen for daytime use while at rest and nighttime use differ and the average of the two amounts is greater than 4 liters per minute (lpm)


name: Rectal control system for vaginal insertion, for long term use, includes pump and all supplies and accessories, any type each


name: For diabetics only, multiple density insert, made by direct carving with cam technology from a rectified cad model created from a digitized scan of the patient, total contact with patient's foot, including arch, base layer minimum of 3/16 inch material of shore a 35 durometer (or higher), includes arch filler and other shaping material, custom fabricated, each


name: Synthetic resorbable wound dressing, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing


name: Synthetic resorbable wound dressing, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing


name: Cold or hot fluid bottle, ice cap or collar, heat and/or cold wrap, any type


name: In-line cartridge containing digestive enzyme(s) for enteral feeding, each


name: Generator, neurostimulator (implantable), non-rechargeable, with transvenous sensing and stimulation leads


name: No implantable/insertable device used with device-intensive procedures


name: Fluid circulating cold pad with pump, any type


name: Portable oxygen contents, liquid, 1 month's supply = 1 unit, prescribed amount at rest or nighttime exceeds 4 liters per minute (lpm)


name: Home ventilator, multi-function respiratory device, also performs any or all of the additional functions of oxygen concentration, drug nebulization, aspiration, and cough stimulation, includes all accessories, components and supplies for all functions


name: Professional services for the administration of subcutaneous immunotherapy or other subcutaneous infusion drug or biological for each infusion drug administration calendar day in the individual's home, each 15 minutes


name: Professional services for the administration of intravenous chemotherapy or other intravenous highly complex drug or biological infusion for each infusion drug administration calendar day in the individual's home, each 15 minutes


name: Brief (20 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)


name: Limited (30 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)


name: Moderate (45 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)


name: Comprehensive (60 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)


name: Extensive (75 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)


name: Limited (30 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)


name: Moderate (45 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)


name: Comprehensive (60 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)


name: Extensive (75 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)


name: Limited (30 minutes) care management home care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)


name: Comprehensive (60 minutes) care management home care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)


name: Blinded administration of convulsive therapy procedure, either electroconvulsive therapy (ect, current covered gold standard) or magnetic seizure therapy (mst, non-covered experimental therapy), performed in an approved ide-based clinical trial, per treatment session


name: Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment


name: Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention, 5-14 minutes


name: Residual score for the knee impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)


name: Residual score for the knee impairment successfully calculated and the score was less than zero (< 0)


name: Residual score for the hip impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)


name: Residual score for the hip impairment not measured because the patient did not complete the lepf prom at initial evaluation and/or near discharge, reason not given


name: Residual score for the lower leg, foot or ankle impairment successfully calculated and the score was equal to zero (0) or greater than zero ( > 0)


name: Residual score for the lower leg, foot or ankle impairment successfully calculated and the score was less than zero (< 0)


name: Residual score for the lower leg, foot or ankle impairment not measured because the patient did not complete the lepf prom at initial evaluation and/or near discharge, reason not given


name: Residual score for the low back impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)


name: Residual score for the low back impairment successfully calculated and the score was less than zero (< 0)


name: Risk-adjusted functional status change residual score for the low back impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate


name: Residual score for the shoulder impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)


name: Residual score for the shoulder impairment successfully calculated and the score was less than zero (< 0)


name: Residual score for the elbow, wrist or hand impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)


name: Residual score for the elbow, wrist or hand impairment successfully calculated and the score was less than zero (< 0)


name: Uri episodes when the patient had competing diagnoses on or three days after the episode date (e.g., intestinal infection, pertussis, bacterial infection, lyme disease, otitis media, acute sinusitis, acute pharyngitis, acute tonsillitis, chronic sinusitis, infection of the pharynx/larynx/tonsils/adenoids, prostatitis, cellulitis, mastoiditis, or bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia/gonococcal infections, venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis or uti, and acne)


name: Performance of trans-abdominal or trans-vaginal ultrasound and pregnancy location documented


name: Documentation of medical reason(s) for not including pt category, thickness, ulceration and mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors (e.g., negative skin biopsies, insufficient tissue, or other documented medical reasons)


name: Pathology report does not include the pt category, thickness, ulceration and mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors


name: Patient did not undergo abdominal imaging and did not have a documented reason for not undergoing abdominal imaging in the submission period


name: Cms innovation center models, home visit for patient assessment performed by clinical staff for an individual not considered homebound, including, but not necessarily limited to patient assessment of clinical status, safety/fall prevention, functional status/ambulation, medication reconciliation/management, compliance with orders/plan of care, performance of activities of daily living, and ensuring beneficiary connections to community and other services. (for use only in medicare-approved cms innovation center models); may not be billed for a 30 day period covered by a transitional care management code


name: Adult patients 18 years of age or older with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5


name: Index event date phq-9 or phq-9m score greater than 9 documented during the twelve month denominator identification period


name: Patient presented with a minor blunt head trauma and had a head ct ordered for trauma by an emergency care provider (G9530)


name: Patient has documentation of ventricular shunt, brain tumor, multisystem trauma, or is currently taking an antiplatelet medication including: abciximab, anagrelide, cangrelor, cilostazol, clopidogrel, dipyridamole, eptifibatide, prasugrel, ticlopidine, ticagrelor, tirofiban, or vorapaxar


name: Patient sustained bladder injury at the time of surgery or discovered subsequently up to 30 days post-surgery


name: Patient did not sustain bladder injury at the time of surgery nor discovered subsequently up to 30 days post-surgery


name: Patient sustained bowel injury at the time of surgery or discovered subsequently up to 30 days post-surgery


name: Patient did not sustain a bowel injury at the time of surgery nor discovered subsequently up to 30 days post-surgery


name: Final reports with documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)


name: Final reports without documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)


name: Psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi))


name: Facility service(s) for the onsite acute care treatment of a nursing facility resident with fluid or electrolyte disorder. (may only be billed once per day per beneficiary). this service is for a demonstration project


name: Patient unable to complete the lepf prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available (G9729)


name: Patient unable to complete the lepf prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available (G9727)


name: Patient unable to complete the low back fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available


name: Patient unable to complete the shoulder fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available


name: Patient unable to complete the elbow/wrist/hand fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available


name: Documentation of medical reason(s) for not including a recommended interval and modality for follow-up or for no follow-up, and source of recommendations (e.g., patients with unexplained fever, immunocompromised patients who are at risk for infection)


name: Documentation of medical reason(s) for not achieving at least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) within the 30 minutes immediately before or 15 minutes immediately after anesthesia end time (e.g., emergency cases, intentional hypothermia, etc.)


name: At least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) not achieved within the 30 minutes immediately before or 15 minutes immediately after anesthesia end time, reason not given


name: First medicare diabetes prevention program (mdpp) core session was attended by an mdpp beneficiary under the mdpp expanded model (em). a core session is an mdpp service that: (1) is furnished by an mdpp supplier during months 1 through 6 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for core sessions


name: Four total medicare diabetes prevention program (mdpp) core sessions were attended by an mdpp beneficiary under the mdpp expanded model (em). a core session is an mdpp service that: (1) is furnished by an mdpp supplier during months 1 through 6 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for core sessions


name: Nine total medicare diabetes prevention program (mdpp) core sessions were attended by an mdpp beneficiary under the mdpp expanded model (em). a core session is an mdpp service that: (1) is furnished by an mdpp supplier during months 1 through 6 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for core sessions


name: Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 7-9 under the mdpp expanded model (em). a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary did not achieve at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 7-9


name: Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 10-12 under the mdpp expanded model (em). a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary did not achieve at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 10-12


name: Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 7-9 under the mdpp expanded model (em). a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.the beneficiary achieved at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 7-9


name: Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 10-12 under the mdpp expanded model (em). a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary achieved at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 10-12


name: The mdpp beneficiary achieved at least 5% weight loss (wl) from his/her baseline weight in months 1-12 of the mdpp services period under the mdpp expanded model (em). this is a one-time payment available when a beneficiary first achieves at least 5% weight loss from baseline as measured by an in-person weight measurement at a core session or core maintenance session


name: The mdpp beneficiary achieved at least 9% weight loss (wl) from his/her baseline weight in months 1-24 under the mdpp expanded model (em). this is a one-time payment available when a beneficiary first achieves at least 9% weight loss from baseline as measured by an in-person weight measurement at a core session, core maintenance session, or ongoing maintenance session


name: Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 13-15 under the mdpp expanded model (em). an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 13-15


name: Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 16-18 under the mdpp expanded model (em). an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 16-18


name: Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 19-21 under the mdpp expanded model (em). an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 19-21


name: Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 22-24 under the mdpp expanded model (em). an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 22-24


name: Bridge payment: a one-time payment for the first medicare diabetes prevention program (mdpp) core session, core maintenance session, or ongoing maintenance session furnished by an mdpp supplier to an mdpp beneficiary during months 1-24 of the mdpp expanded model (em) who has previously received mdpp services from a different mdpp supplier under the mdpp expanded model. a supplier may only receive one bridge payment per mdpp beneficiary


name: Mdpp session reported as a line-item on a claim for a payable mdpp expanded model (em) hcpcs code for a session furnished by the billing supplier under the mdpp expanded model and counting toward achievement of the attendance performance goal for the payable mdpp expanded model hcpcs code (this code is for reporting purposes only)


name: Bundled payments for care improvement advanced (bpci advanced) model home visit for patient assessment performed by clinical staff for an individual not considered homebound, including, but not necessarily limited to patient assessment of clinical status, safety/fall prevention, functional status/ambulation, medication reconciliation/management, compliance with orders/plan of care, performance of activities of daily living, and ensuring beneficiary connections to community and other services; for use only for a bpci advanced model episode of care; may not be billed for a 30-day period covered by a transitional care management code


name: Miscellaneous external component, supply or accessory for use with the argus ii retinal prosthesis system


name: Miscellaneous component, supply or accessory for use with total artificial heart system


name: Powered upper extremity range of motion assist device, elbow, wrist, hand with single or double upright(s), includes microprocessor, sensors, all components and accessories, custom fabricated


name: Powered upper extremity range of motion assist device, elbow, wrist, hand, finger, single or double upright(s), includes microprocessor, sensors, all components and accessories, custom fabricated


name: Documentation of medical reason for not screening for tb or interpreting results (i.e., patient positive for tb and documentation of past treatment; patient who has recently completed a course of anti-tb therapy)


name: Tb screening not performed or results not interpreted, reason not given


name: Disease activity not assessed, reason not given


name: >=50% of total number of a patient's outpatient ra encounters assessed


name: <50% of total number of a patient's outpatient ra encounters assessed


name: Patients with an active diagnosis or history of cancer (except basal cell and squamous cell skin carcinoma), patients who are heavy tobacco smokers, lung cancer screening patients


name: Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5


name: Adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5. either phq-9 or phq-9m score was not assessed or is greater than or equal to 5


name: Patient had only urgent care visits during the performance period (M1021)


name: Imaging of the head (ct or mri) was obtained


name: Documentation of patients with primary headache diagnosis and imaging other than ct or mri obtained


name: Adults currently taking pharmacotherapy for oud


name: Adults who have at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days


name: Adults who have not had at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days


name: Patients with a diagnosis of lumbar spine region cancer at the time of the procedure


name: Patients with a diagnosis of lumbar spine region fracture at the time of the procedure


name: Patients with a diagnosis of lumbar spine region infection at the time of the procedure


name: Patients with a diagnosis of lumbar idiopathic or congenital scoliosis


name: Prescribed anticoagulant medication during the performance period, history of gi bleeding, history of intracranial bleeding, bleeding disorder and specific provider documented reasons: allergy to aspirin or anti-platelets, use of non-steroidal anti-inflammatory agents, drug-drug interaction, uncontrolled hypertension > 180/110 mmhg or gastroesophageal reflux disease


name: Patient was a permanent nursing home resident at any time during the performance period


name: Patient was in hospice or receiving palliative care at any time during the performance period


name: Patient died prior to the end of the performance period (M1060)


name: Patient not screened for future fall risk, reason not given


name: Grafix prime, grafixpl prime, stravix and stravixpl, per square centimeter (add-on, list separately in addition to primary procedure)


name: Amnioexcel, amnioexcel plus or biodexcel, per square centimeter (add-on, list separately in addition to primary procedure)


name: Surgigraft, per square centimeter (add-on, list separately in addition to primary procedure)


name: Cellesta flowable amnion (25 mg per cc); per 0.5 cc


name: Epifix, per square centimeter (add-on, list separately in addition to primary procedure)


name: Epicord, per square centimeter (add-on, list separately in addition to primary procedure)


name: Amnioarmor, per square centimeter (add-on, list separately in addition to primary procedure)


name: Artacent ac, per square centimeter (add-on, list separately in addition to primary procedure)


name: Restorigin, per square centimeter (add-on, list separately in addition to primary procedure)


name: Coll-e-derm, per square centimeter (add-on, list separately in addition to primary procedure)


name: Novachor, per square centimeter (add-on, list separately in addition to primary procedure)


name: Puraply, per square centimeter (add-on, list separately in addition to primary procedure)


name: Puraply am, per square centimeter (add-on, list separately in addition to primary procedure)


name: Puraply xt, per square centimeter (add-on, list separately in addition to primary procedure)


name: Skin te, per square centimeter (add-on, list separately in addition to primary procedure)


name: Matrion, per square centimeter (add-on, list separately in addition to primary procedure)


name: Derma-gide, per square centimeter (add-on, list separately in addition to primary procedure)


name: Xwrap, per square centimeter (add-on, list separately in addition to primary procedure)


name: Incontinence product, disposable, penile wrap, each


name: Hearing aid, contralateral routing device, monaural, in the ear (ite)


name: Hearing aid, contralateral routing device, monaural, in the canal (itc)


name: Hearing aid, contralateral routing device, monaural, behind the ear (bte)


name: Hearing aid, contralateral routing, monaural, glasses


name: Hearing aid, contralateral routing system, binaural, ite/itc


name: Hearing aid, contralateral routing system, binaural, ite/bte


name: Hearing aid, contralateral routing system, binaural, itc/itc


name: Hearing aid, contralateral routing system, binaural, itc/bte


name: Hearing aid, contralateral routing system, binaural, bte/bte


name: binaural hearing aid, contralateral routing system, glasses (treatment)


name: Dispensing fee, contralateral routing system, binaural


name: Autoimmune (systemic lupus erythematosus), IgG and IgM analysis of 80 biomarkers, utilizing serum, algorithm reported with a risk score


name: Neurology (autism), 32 amines by LC-MS/MS, using plasma, algorithm reported as metabolic signature associated with autism spectrum disorder


name: Antibody, Treponema pallidum, total and rapid plasma reagin (RPR), immunoassay, qualitative


name: Oncology (breast), immunohistochemistry, protein expression profiling of 4 biomarkers (matrix metalloproteinase-1 [MMP-1], carcinoembryonic antigen-related cell adhesion molecule 6 [CEACAM6], hyaluronoglucosaminidase [HYAL1], highly expressed in cancer protein [HEC1]), formalin-fixed paraffin-embedded precancerous breast tissue, algorithm reported as carcinoma risk score


name: Candida species panel (C. albicans, C. glabrata, C. parapsilosis, C. kruseii, C. tropicalis, and C. auris), amplified probe technique with qualitative report of the presence or absence of each species


name: Oncology (colorectal), microRNA, RT-PCR expression profiling of miR-31-3p, formalin-fixed paraffin-embedded tissue, algorithm reported as an expression score


name: CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, targeted sequence analysis (ie, CYP2D6-2D7 hybrid gene) (List separately in addition to code for primary procedure)


name: CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, targeted sequence analysis (ie, CYP2D7-2D6 hybrid gene) (List separately in addition to code for primary procedure)


name: CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, targeted sequence analysis (ie, non-duplicated gene when duplication/multiplication is trans) (List separately in addition to code for primary procedure)


name: CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, targeted sequence analysis (ie, 5' gene duplication/multiplication) (List separately in addition to code for primary procedure)


name: CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, targeted sequence analysis (ie, 3' gene duplication/multiplication) (List separately in addition to code for primary procedure)


name: Immunoglobulin paraprotein (M-protein), qualitative, immunoprecipitation and mass spectrometry, blood or urine, including isotype


name: Comparative DNA analysis using multiple selected single-nucleotide polymorphisms (SNPs), urine and buccal DNA, for specimen identity verification


name: Oncology (lung), mass spectrometric analysis of galectin-3-binding protein and scavenger receptor cysteine-rich type 1 protein M130, with five clinical risk factors (age, smoking status, nodule diameter, nodule-spiculation status and nodule location), utilizing plasma, algorithm reported as a categorical probability of malignancy


name: Oncology (uveal melanoma), mRNA, gene expression profiling by real-time RT-PCR of 15 genes (12 content and 3 housekeeping), utilizing fine needle aspirate or formalin-fixed paraffin-embedded tissue, algorithm reported as risk of metastasis


name: Drug test(s), definitive, 90 or more drugs or substances, definitive chromatography with mass spectrometry, and presumptive, any number of drug classes, by instrument chemistry analyzer (utilizing immunoassay), urine, report of presence or absence of each drug, drug metabolite or substance with description and severity of significant interactions per date of service


name: Oncology, response to chemotherapy drugs using motility contrast tomography, fresh or frozen tissue, reported as likelihood of sensitivity or resistance to drugs or drug combinations


name: Possible increased risk of solid malignant tumors


name: Cyclical centrifugal peeling of skin (palmoplantar surfaces)


name: Focal areas of mild spongiosis that spread centrifugally


name: Compact parakeratotic layer under stratum corneum


name: Proliferation of basal keratinocytes, forming new strata granulosa and corneum


name: Split occurs above newly regenerated orthokeratotic stratum corneum


name: Intracristal swelling with denser matrix in keratinocyte mitochondria


name: One or 2 extraordinarily enlarged fingers


name: Bone-spicule pattern of pigmentary deposits in retinal midperiphery


name: Rod responses reduced or extinguished seen on electroretinography (ERG)


name: Cone responses reduced or extinguished seen on ERG


name: Central hypopigmented confluent islands seen on fundus autofluorescence (FAF)


name: Multiple diffuse parafoveal hypopigmented lesions seen on FAF


name: Severe foveal 'dipping' seen on optical coherence tomography (OCT)


name: Outer retinal tissue thinning seen on OCT


name: Diffuse cystic-like lesions in choroidal layer seen on OCT


name: Elevated long chain fatty acids Caused by mutation in the peroxisome biogenesis factor 5 gene (PEX5, 600414.0001)


name: Reduced tooth movement with orthodontic treatment


name: Protruding cervical root morphology (in primary and/or secondary dentition)


name: Increased cervical cementum mineral density


name: Cementocyte-like cells in cervical cementum


name: Intellectual developmental impairment, mild to severe


name: Parafoveal retinal pigment epithelium atrophy, well-circumscribed and progressive


name: Susceptibility to human papillomavirus (HPV) genotypes


name: Pityriasis versicolor-like lesions, disseminated


name: Poor production of certain cytokines (IL-12, gamma-interferon, IL-10, IL-6, TNF-alpha) after stimulation


name: Spontaneous miscarriages due to placental bleeding


name: Placental microabscesses resulting in sepsis and fetus mortus


name: Absent response to polysaccharide antigens


name: Recurrent infections of mucous membranes


name: Myeloid maturation arrest intermittently seen on bone marrow biopsies


name: Recurrent condylomatous warts in genital and thigh area


name: Hypoglycemia, stress-induced (precipitated by infection)


name: Multiple small luminae with a sieve-like appearance seen on microscopic examination


name: Hypomineralized linear demarcated opacities


name: Abnormalities consistent with Leigh syndrome seen on brain imaging


name: Decreased activity of mitochondrial respiratory chain complex I in various tissues


name: Disarray of liver structure histologically


name: Ductal metaplasia at periphery of portal tracts


name: Absent or abnormal visual evoked potential responses


name: No signs of active bone remodeling/resorption


name: Sharp transition from compact to trabecular bone


name: Anomalous pericapillary localization of osteoclasts


name: Intense sclerosis of cranium, especially at base


name: 'Harlequin mask' or 'space-alien face' appearance


name: Sclerosis of anterior cranial fossa floor ('prominent eyebrow' appearance)


name: Elevated serum aspartate-aminotranferase (AST)


name: Elevated serum lactate dehydrogenase (LDH)


name: Greater deviation of stature than head size


name: Markedly advanced osseous maturation for height and age


name: Failure to generate somatomedin (or insulinlike growth factor, IGF1) in response to growth hormone


name: Low IGF1 despite normal or increased levels of GH


name: Metaphyseal broadening of distal femora, mild


name: Metaphyseal broadening of proximal tibia, mild


name: ARHGEF6, IVS1AS, T-C, -11 (dbSNP rs140322310)


name: Reduced or increased thyroxine-binding globulin


name: Female carriers may have premature ovarian insufficiency


name: Impaired intellectual development, borderline to severe


name: Elevated urinary pyridinoline crosslink profile


name: Hearing loss, bilateral mixed or conductive


name: NDUFA6, 1-BP DEL, NT309 (dbSNP rs763006208)


name: NDUFA6, 1-BP DEL, NT355 (dbSNP rs781099275)


name: Congenital palsy of right cranial nerve III


name: Congenital palsy of right cranial nerve IV


name: Sensorineural deafness, unilateral severe


name: Extinguished electroretinogram responses bilaterally


name: Absence of acetylcholinesterase (AChE) from neuromuscular junction seen on muscle biopsy


name: Focal degeneration of postsynaptic junctional folds


name: Abnormal encasement of presynaptic membrane by Schwann cells


name: DNAH9, LYS1881GLU AND ARG2965HIS (dbSNP rs375908701)


name: Low serum concentration of GH-binding protein


name: Respiratory insufficiency due to neuropathy


name: Normal to increased occipitofrontal circumference (OFC)


name: Delayed ossification of cervical vertebral bodies


name: Abnormal glycosylation of transferrin, type 1 pattern


name: Abnormal mitochondria seen on muscle biopsy


name: Deafness, sensorineural, moderate to profound


name: Abnormal glycosylation of serum transferrin, type 2 pattern


name: SOHLH1, IVS3AS, G-A, -1 (dbSNP rs140132974)


name: Sclerosis, particularly of the base of the skull


name: Sclerotic vertebral endplates ('rugger-jersey' spine)


name: Concentric arcs of sclerosis in iliac wings ('bone-within-bone' sign)


name: Increased bone density in epiphyseal growth plates of long bones


name: Band-like sclerosis of vertebral endplates ('rugger-jersey' spine)


name: Nonhomogeneous sclerosis of metadiaphyses (distal femora, tibiae, and fibulae, and proximal fibulae and tibiae)


name: 'Erlenmeyer flask' deformity of distal femora and proximal tibiae


name: Slow stimuli transmission in anterior visual pathways


name: Optic nerve atrophy due to bone compression


name: Olfactory nerve atrophy due to bone compression


name: Slow stimuli transmission in bilateral peripheral auditory pathways


name: Chronic denervation and reinnervation (bulbar and limb musculature)


name: Increase of bony and cartilaginous trabeculae


name: Significant reduction of medullary space


name: Lack of multinucleated cells in bone marrow


name: Lack of active osteoblasts in bone marrow


name: Alternating bands of radiodensity and lucency at metaphyses


name: Abnormal glycosylation of alpha-dystroglycan


name: Lymphatic malformations (lip, oral mucosa, neck and tongue)


name: Diffuse mottling of retinal pigment epithelium


name: Progressive hearing loss, severe-to-profound


name: Telangiectases in both sun-exposed and sun-protected areas


name: Alopecia, patchy, over areas of prominent telangiectases


name: No peroxisomes visualized in cultured fibroblasts


name: Peripheral accumulation of abnormal mitochondria seen on muscle biopsy


name: Mitochondrial respiratory chain deficiencies of complexes III and IV seen on liver biopsy


name: Increased patellar and Achilles reflexes


name: T2-weighted abnormalities in the basal ganglia


name: Lateral subluxation of tarsal navicular bones


name: Hyperkeratotic follicular papules on cheeks and arms


name: Loss of Purkinje cells in the cerebellar cortex


name: Aberrant dendrite arborization of Purkinje cells in the cerebellum


name: Decrement of compound action muscle potentials (CMAP) seen on repetitive nerve stimulation


name: Conductive hearing loss (in 1 heterozygote)


name: Leukodystrophy of the subcortical region, cerebellum, brainstem, and spinal cord


name: Increased CSF glycine, glutamate, and lactate


name: Fibroblasts show decreased mitochondrial complex II activity


name: Decreased mitochondrial membrane potential


name: Decreased oxidative phosphorylation and ATP production


name: Decreased complex I/III and II/III activity seen on muscle biopsy


name: Macular retinal pigment epithelium (RPE) changes, mild


name: Aberrant vascular arcades on fundus fluorescein angiography (FFA)


name: Retrograde flow of contrast in lymphatics into mediastinum


name: Lymphatic valves appear absent or dysfunctional


name: Retrograde flow of contrast in lymphatics into retroperitoneum and abdomen


name: Proliferation of lymphatic channels in retroperitoneum


name: Retrograde flow of contrast in lymphatics into neck


name: Proliferation of lymphatic channels around the spine


name: Markedly increased dermal vascular structures


name: Abnormal large lymphatic structures seen on lung biopsy


name: Abnormal retrograde pulmonary lymphatic perfusion of right lung seen on magnetic resonance lymphangiography


name: Proliferation of lymphatic channels in the lungs


name: Amyotrophic paresis, asymmetric (upper limbs initially)


name: Hyperreflexia without spasticity in atrophic limbs


name: Atrophy of the hippocampus, severe, seen on MRI


name: Decreased GPI-anchored proteins on granulocyte surface


name: Diffuse and multifocal epileptic discharges


name: Continuous slow spike and wave activity during sleep


name: Absence of upper extremity below the elbow


name: Bronchial tree branching at lower level than normal


name: Agenesis of branches of pulmonary artery


name: Flexion contracture of elbow with pterygia


name: Only 1 or 2 finger-like appendages per extremity


name: Hassal-Henle bodies at corneal periphery


name: Reduced compound muscle action potential (CMAP) amplitudes


name: Reduced sensory nerve actions potential (SNAP) amplitudes


name: Normal nerve conduction velocities (NCV)


name: Alveolar macrophages are small and lack foamy inclusions


name: Increased urinary homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA)


name: Decreased urinary norepinephrine and dopamine


name: Renal cysts, small (less than 1 cm to 3 cm)


name: Absent inner and outer dynein arms of the cilia see on electron microscopy of patient respiratory epithelial cells


name: Respiratory infections, chronic, due to defective ciliary clearance


name: Neurogenic atrophy seen on skeletal muscle biopsy


name: Focal and multifocal spike abnormalities seen on EEG


name: Elevated luteinizing hormone (LH, see 152780) levels


name: Elevated follicle-stimulating hormone (FSH, see 136530) levels


name: LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 8


name: Bullae (primarily on trunk and flexural surface of arms)


name: Hyperpigmentation, transient, at lesion sites


name: Loosely packed interdigitating corneocytes


name: Globular inclusions with abnormal central vesicles


name: Neurodevelopmental regression (between 2 and 10 years)


name: Intellectual disability, variable, mild to severe


name: Disorganization of seminiferous tubular structure


name: Immature germ cells in lumen of seminiferous tubules


name: Overrepresentation of early round spermatids in seminiferous tubules


name: Decreased numbers of type 2 innate lymphoid cells (ILC2s)


name: Vestibular dysfunction, mild, age-dependent


name: Hot flushes (in the third decade of life)


name: Dysmorphic facial features, progeroid-like


name: Skeletal muscle biopsy from 1 patient showed mitochondrial DNA depletion


name: Patient cells show increased number of sister chromatid exchanges (SCEs)


name: Symmetric changes in the thalami and midbrain


name: COX-deficient ragged-red fibers seen on skeletal muscle biopsy


name: 'Bone-within-bone' appearance of vertebrae


name: Increased density of central pelvic bones


name: Generalized increase in density of long bones


name: Discrete areas of increased bone density in femoral head


name: Dysregulated cytokine secretion by T cells


name: Camptodactyly of the fourth and fifth fingers


name: Spermatogonial cells on testicular histology


name: Meiotic/postmeiotic cells on testicular histology


name: Sertoli cell-only pattern in some seminiferous tubules


name: White matter abnormalities in the corpus callosum and surrounding areas


name: No spermatogenic cells seen on testicular biopsy


name: Sertoli cell-only pattern seen on testicular biopsy


name: Low or nondetectable estradiol (E2) levels


name: Sensorimotor peripheral neuropathy, primarily axonal


name: Myopathic changes, mild, seen on skeletal muscle biopsy


name: Decreased subsets of T helper and T memory cells


name: Inflammatory plaques of the palms and soles


name: Perivascular infiltrate containing CD8+ T cells


name: Muscle weakness, proximal (lower and upper limbs may be affected)


name: Variable dystrophic changes seen on muscle biopsy


name: White matter abnormalities seen on brain imaging


name: Hearing loss, bilateral symmetric postlingual


name: Impaired intellectual development, severe to profound


name: Contractures of joints of upper and lower extremities


name: Seizures, febrile and nonfebrile, intractable


name: Hearing loss, sensorineural, progressive (moderate to severe, late onset)


name: Decreased rod and mixed cone-rod responses seen on electroretinography


name: Elevated methanethiol and dimethylsulfide (DMS) in breath


name: Elevated DMS, DMSO, and DMSO(2) in blood, CSF, and urine


name: Morphologic defects of all sperm flagella


name: Axonemal and periaxonemal defects seen on transmission electron microscopy


name: Disorganization of the fibrous sheath seen on transmission electron microscopy


name: Lymphedema, predominantly of lower extremities


name: Impaired intellectual development, moderate


name: Elongation of the superior cerebellar peduncles


name: Cerebral masses consistent with cavernous malformation


name: Delayed ossification of basal occipital bone


name: Delayed ossification of posterior elements


name: Ossification defects in appendicular skeleton


name: Enlarged distance from epiphyses to metaphyseal edge


name: Bone marrow shows selective erythroid hypoplasia


name: Overlapping fingers (primarily third and fourth fingers)


name: Short proximal phalanges in second through fourth fingers


name: Missing or extra flexion creases on fingers


name: Dysmorphic and short proximal and distal phalanges


name: Inflammatory changes in intestinal tract, chronic


name: Neurodegeneration after normal early development


name: Sensorimotor axonal or demyelination neuropathy


name: Seizures, myoclonic, atonic, intractable


name: Hypotrichosis of scalp, especially anteriorly


name: Follicular accentuation, especially over bony prominences


name: Flattened and partially absent cuticular scales


name: Dizziness on standing due to low blood pressure


name: Fainting on standing due to low blood pressure


name: Decreased or absent plasma levels of norepinephrine and epinephrine


name: Normal dopamine beta-hydroxylase activity


name: Markedly elevated thyroid-stimulating hormone (TSH)


name: Focal lymphangiectasia in terminal ileum


name: Decreased motor nerve conduction velocities, severe (less than 10 m/s)


name: Little or no compact myelin seen on sural nerve biopsy


name: Impaired or absent intellectual development


name: Hypomyelination seen on sural nerve biopsy


name: Widening of the nodes of Ranvier and paranodal junctional gaps


name: Atypical onion bulb formation by the basal lamina


name: Loss of transverse myelin bands at the paranodal domains


name: Myelin loops are loosely or not connected to the axolemma


name: Poor or absent swallowing due to hypotonia


name: Increased left ventricular end-diastolic volume


name: Low coenzyme A levels in patient fibroblasts


name: Relatively low levels of long chain acylcarnitines (C16, C18)


name: Extinguished scotopic and photopic responses seen on ERG


name: Retinal pigment epithelium atrophy seen on fluorescein angiography (FA)


name: Perifoveal retinal vascular leakage on FA


name: Flattening of foveal border seen on spectral-domain optical coherence tomography (SD-OCT)


name: Severe thinning of interdigitation zones


name: Capillary malformations (head, neck, trunk, extremities)


name: Telangiectases (lips, perioral area, upper thorax)


name: Arteriovenous malformations (cutaneous, subcutaneous, muscular, bony)


name: Developmental delay, mild, before onset of seizures


name: Hypogammaglobulinemia: Decreased CD4+ and CD8+ T cells


name: Delayed walking (usually by 5 years of age)


name: Delayed intellectual development, mild to severe


name: Impaired intellectual development, moderate to severe


name: Intellectual developmental deficit, mild to moderate


name: White matter abnormalities consistent with Leigh syndrome


name: Mitochondrial complex I deficiency in various tissues


name: Borderline low parathyroid hormone (PTH)


name: Skeletal muscle biopsy shows variation in fiber size